How Software is Eating Care Delivery in Healthcare
By Julie Yoo | Jul 31, 2019
We believe right now is a truly transformative moment in the healthcare market—particularly in care delivery.
A CRISPR startup is testing pig organs in monkeys to see if they’re safe for us
By Karen Weintraub | Jun 12, 2019
Gene-editing company eGenesis is now carrying out experiments to help solve a critical shortage of human organs available for transplant.
Japan approves first human-animal embryo experiments
By David Cyranoski | Jul 26, 2019
The research could eventually lead to new sources of organs for transplant, but ethical and technical hurdles need to be overcome.
Billionaire Sean Parker is nerding out on cancer research.
By Rebecca Robbins | Jul 9, 2019
Soon after cancer immunotherapy pioneer Jim Allison won the Nobel Prize in medicine last October, his billionaire benefactor Sean Parker called with a cryptic message: Someone would need to be home on Friday afternoon
Cancer biologists identify new drug combo
By Anne Trafton | Jul 10, 2019
Two drugs that block cell division synergize to kill tumor cells.
A third CRISPR baby may have already been born in China
By Antonio Regalado | Jul 3, 2019
Another genetically edited baby is due, but the world may never learn of its birth if the Chinese government decides to keep it a secret.
Can Marijuana Help Cure the Opioid Crisis?
By Austin Frakt | Jun 17, 2019
Marijuana plants in a grow room in Gardena, Calif. A new study has cast doubt on the theory that medical marijuana liberalization can prevent opioid overdose deaths.
New Finding Advances the Search for a Universal Flu Vaccine
By Debbie Ponchner | Jun 3, 2019
Antibodies to a portion of the influenza virus that varies relatively little from strain to strain may provide flu protection in humans
The world's rivers are contaminated with antibiotics, new study shows
By Kara Fox | May 27, 2019
The world's rivers are widely contaminated with antibiotics, according to a new global study, the first of its kind.
Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself
By Ellie Kincaid and Michela Tindera | May 14, 2019
When Rachel Haurwitz started her biology Ph.D. at the University of California, Berkeley, the award-winning biochemist Jennifer Doudna suggested Haurwitz investigate part of a bacterial immune system.